47. Inouye SK. Delirium in older persons. N Engl J Med 2006; 354: 1157–1165. 48. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 389: 911–922. 49. Jirák R. Deliria u pacientů vyššího věku. In: Kalvach Z, Zadák Z, Jirák R, et al. Geriatrie a gerontology. Praha: Grada Publishing 2004: 258–263. 50. Jones SF, Pisani MA. ICU delirium: an update. Curr Opin Crit Care 2012; 18(2): 146–151. 51. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005; 53(10): 1658–1666. 52. Kenny J-ES. The cerebral circulation and sepsis-associated delirium. Avondale Estates, GA: Pulm CCM 2016. /https://pulmccm.org/critical-care-review/cerebral-circulation-sepsis-associated-delirium/ 53. Khan BA, Zawahiri M, Campbell NL, Boustani MA. Biomarkers for Delirium – a review. J Am Geriatr Soc 2011; 59(2): S258–S261. 54. Kim H, Chung S, Joo YH, Lee JS. The major risk factors for delirium in a clinical setting. Neuropsychiatr Dis Treat 2016; 12: 1787–1793. 55. Kuswardhani TRA, Sugi YS. Factors related to the severity of delirium in the elderly patients with infections. Gerontol Geriatr Med 2017; 3: 2333721417739188. 56. Landi F, Dell’Aquilla G, Collamati A, et al. Anticholinergic drugs use and negative outcomes among the frail elderly population living in a nursing home. J AM Med Dir Assoc 2014; 15(11): 825–829.
96 / D E L I R I A z p o h le d u p s yc h i at r a
Ukázka elektronické knihy, UID: KOS285841
57. Lawlor PG, Gagnon B, Mancini IL, et al. Occurence, causes, and outcome of delirium in patiens with advanced cancer: a prospective study. Arch Intern Med 2000; 160(6): 786–795. 58. Lipowski ZJ. Delirium (acute confusional states). JAMA 1987; 258(13): 1789–1792. 59. Liu CY, Juang YY, Liang HY, et al. Efficacy of risperidone in treating the hyperactive symptom sof delirium. Internat Clin Psychopharmacol 2004; 19: 165–168. 60. Lonergan E, Britton AM, Luxenberg J. Antipsychotics for delirium. Cochrane Database Syst Rev 2007: CD005594. 61. Long D, Long B, Koyfman A. The emergency medicine management of severe alcohol withdrawal. Am J Emerg Med 2017; 35(7): 1005–1011 62. Lorenzl S, Füsgen I, Noachtar S. Acute confusional states in elderly – diagnosis and treatment. Deutsches Ärzteblatt International 2012; 109(21): 391–400. 63. Magni E, Le Petitcorps H, Poclumban M, et al. Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: a prospective care series. PLoS One 2018; 13(2): e0193034. 64. Maldonado J. Neuropathogenesis of delirium: review of current ethiologic theories of common pathways. Am J Geriatr Psychiatry 2013; 21(12): 1190–1222. 65. Martins CHT, De Marchi Assuncao C. Delirium as a symptom of previously asymptomatic HIV Patient with brain toxoplasmosis – case report and review of literature. EC Neurology 2018; 10(5): 367–372.
L i t er at u r a / 97
Ukázka elektronické knihy, UID: KOS285841
66. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clinical Therapeutics 2014; 36(11): 1489–1511. 67. Meagher D, Leonard M. The active management of delirium: Improving detection and treatment. Adv Psychiat Treat 2008; 14(4): 292–301. 68. Mitášová A, Bednařík J, Košťálová M, et al. Standardizace české verze The Confucion Assessment Method for the Intensive Care Unit (CAM-ICUcz). Cesk Slov Neurol N 2010; 73/106(3): 258–266. 69. Mittal SH, Mittal S, Govil T. The uncommon syndrome of pancreatic encephalopathy. Astrocyte 2016; 2: 185–186. 70. McKenzie R, Stewart MT, Bellantoni MF, FinucaneTE. Bacteriuria in individuals who become delirious. Am J Med 2014; 127(4): 255–257. 71. MKN-10. Mezinárodní statistická klasifikace nemocí a přidružených zdravotních problémů. Praha: Ústav zdravotnických informací a statistiky 1992. 72. Nevin RL, Croft AM. Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives. Malar J 2016; 15: 332. 73. NICE Guidelines. Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ 2010; 341. / doi.org/10.1136/bmj.c3704/ 74. Nishanthi A, Vimal M, Sandhiya S, Dkhar SA. Orexin receptors: a journey through ti the development of suvorexant, the new sleeping pill. Int J Basic Clin Pharmacol 2016; 5(3): 573–578. 75. Okumura A, Nakano T, Fukumoto Y, et al. Delirious behavior in childern with influenza: its clinical features and EEG findings. Brain Development 2005; 27(4): 271–274.
98 / D E L I R I A z p o h le d u p s yc h i at r a
Ukázka elektronické knihy